Figure 1From: Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapySurvival of patients treated with different neoadjuvant chemotherapy regimens. (A) Progression-free survival and (B) overall survival.Back to article page